4'-geranyloxyferulic acid-N(omega)-nitroarginine methyl ester

an anticarcinogenic agent; structure in first source

Also Known As:

4'-geranyloxyferulic acid-N(omega)-nitro-l-arginine methyl ester; GOFA-L-NAME

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Cinnamates: 48
      - Coumaric Acids: 128
        4'-geranyloxyferulic acid-N(omega)-nitroarginine methyl ester: 1
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Basic Amino Acids: 178
    - Arginine: 11940
      - Nitroarginine: 441
        4'-geranyloxyferulic acid-N(omega)-nitroarginine methyl ester: 1
  - Diamino Amino Acids: 101
    - Arginine: 11940
      - Nitroarginine: 441
        4'-geranyloxyferulic acid-N(omega)-nitroarginine methyl ester: 1

Experts

1.	Epifano, Francesco: 1 article (08/2014)
2.	Fiorito, Serena: 1 article (08/2014)
3.	Genovese, Salvatore: 1 article (08/2014)
4.	Kochi, Takahiro: 1 article (08/2014)
5.	Mori, Takayuki: 1 article (08/2014)
6.	Moriwaki, Hisataka: 1 article (08/2014)
7.	Shimizu, Masahito: 1 article (08/2014)
8.	Shirakami, Yohei: 1 article (08/2014)
9.	Tanaka, Takuji: 1 article (08/2014)

Related Diseases

1.	Carcinogenesis 08/15/2014 - "A newly synthesized compound, 4'-geranyloxyferulic acid-N(omega)-nitro-L-arginine methyl ester suppresses inflammation-associated colorectal carcinogenesis in male mice." 08/15/2014 - "Our findings indicate that GOFA-L-NAME is able to inhibit colitis-associated colon carcinogenesis by modulating inflammation, proliferation, apoptosis and the expression of proinflammatory cytokines in mice."
2.	Inflammation (Inflammations) 08/15/2014 - "A newly synthesized compound, 4'-geranyloxyferulic acid-N(omega)-nitro-L-arginine methyl ester suppresses inflammation-associated colorectal carcinogenesis in male mice." 08/15/2014 - "Our findings indicate that GOFA-L-NAME is able to inhibit colitis-associated colon carcinogenesis by modulating inflammation, proliferation, apoptosis and the expression of proinflammatory cytokines in mice."
3.	Colitis 08/15/2014 - "Our findings indicate that GOFA-L-NAME is able to inhibit colitis-associated colon carcinogenesis by modulating inflammation, proliferation, apoptosis and the expression of proinflammatory cytokines in mice."
4.	Adenocarcinoma 08/15/2014 - "Dietary GOFA-L-NAME significantly decreased the proliferation (p < 0.001) and increased the apoptosis (p < 0.001) of colonic adenocarcinoma cells. " 08/15/2014 - "The dietary administration of GOFA-L-NAME after the AOM and DSS treatments significantly reduced the multiplicity of adenocarcinomas (inhibition rates: 100 ppm, 84%, p < 0.001; 500 ppm, 94%, p < 0.001) compared with the AOM + DSS group. "

Related Drugs and Biologics

1.	Cytokines